Improvement of blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension.
Warnock
David G
DG
Bell
P Darwin
PD
D001741:Black or African American; D000584:Amiloride / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D004232:Diuretics / Q000627:therapeutic use; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D053503:Epithelial Sodium Channels; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D026941:Sodium Channel Blockers / Q000008:administration & dosage / Q000627:therapeutic use*; D015222:Sodium Channels / Q000187:drug effects*; D013148:Spironolactone / Q000627:therapeutic use; D016896:Treatment Outcome
D004232:Diuretics; D053503:Epithelial Sodium Channels; D000451:Mineralocorticoid Receptor Antagonists; D026941:Sodium Channel Blockers; D015222:Sodium Channels; D013148:Spironolactone; D000584:Amiloride